IP Verse

Methods Of Mapping Protein Variants - EP3196646

The patent EP3196646 was granted to Hexal on Dec 18, 2019. The application was originally filed on Jan 19, 2016 under application number EP16151956A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3196646

HEXAL
Application Number
EP16151956A
Filing Date
Jan 19, 2016
Status
Granted And Under Opposition
Nov 15, 2019
Grant Date
Dec 18, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBSep 16, 2020SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBWITHDRAWN

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP2975401
OPPOSITIONUS7396687
OPPOSITIONWO2004108948
SEARCHEP2207030
SEARCHWO2004108948
SEARCHWO2006002841
SEARCHWO2010023471
SEARCHWO2014060551

Non-Patent Literature (NPL) Citations (37) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ALESSANDRI ET AL., MABS, (2012), vol. 4, no. 4, pages 509 - 520
DESCRIPTION- BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
DESCRIPTION- CHEN ET AL., GLYCOBIOLOGY, (2009), vol. 19, no. 3, pages 240 - 249
DESCRIPTION- CHERVET ET AL., ANALYTICAL CHEMISTRY, (1996), vol. 68, pages 1507 - 12
DESCRIPTION- DILLON ET AL., JBC, (2008), vol. 283, no. 23, pages 16206 - 16215
DESCRIPTION- GOETZE ET AL., GLYCOBIOLOGY, (2011), vol. 21, no. 7, pages 949 - 959
DESCRIPTION- HIGEL ET AL., PHARMACEUTICAL RESEARCH, (2015), vol. 32, no. 11, pages 3649 - 59
DESCRIPTION- HUBBARD; IVATT, ANN. REV. BIOCHEM., (1981), vol. 50, pages 555 - 583
DESCRIPTION- HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 85, pages 5879 - 5883
DESCRIPTION- KHAWALI ET AL., MABS, (2010), vol. 2, no. 6, pages 613 - 624
DESCRIPTION- LEHTO; HOU, Chemistry and Analysis of Radionuclides, WILEY-VCH VERLAG & CO., (2011), page 170
DESCRIPTION- LIU ET AL., JBC, (2008), vol. 283, no. 43, pages 29266 - 29272
DESCRIPTION- MELMER ET AL., ANAL BIOANAL CHEM, (2010), vol. 398, pages 905 - 914
DESCRIPTION- MELMER ET AL., JOURNAL OF CHROMATOGRAPHY A, (2011), vol. 1218, no. 1, pages 118 - 123
DESCRIPTION- "Protein Liquid Chromatography", Journal of Chromatography Library, ELSEVIER SCIENCE B.V., (2000), vol. 61, page 153
DESCRIPTION- WARD ET AL., NATURE, (1989), vol. 341, pages 544 - 546
OPPOSITION- D. Shin, Y. Kim, H.S. Kim, R. Fuhr, T. Körnicke, "FRI0110 A Phase I Pharmacokinetic Study Comparing SB5, An Adalimumab Biosimilar, And Adalimumab Reference Product (Humira®) in Healthy Subjects.", Annals of the Rheumatic Diseases, (20150000), vol. 74, pages 459 - 460, XP055737262
OPPOSITION- Eric Niederkofler, Amanda Ribar, Kwasi Antwi, Joshua Nicklay, and Urban Kiernan, "MSIA Workflow for Therapeutic Antibodies: Qualitative, Quantitative, and Functional Verification Data from HR/AM Detection of Intact, Reduced, and Peptide-level Forms of Adalimumab", Thermo Scientific, (20140000), pages 1 - 6, XP055737229
OPPOSITION- Irene van den Broek & William D van Dongen‡, "LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications", Bioanalysis, (20150000), vol. 7, no. 15, pages 1943 - 1958, XP055737251
OPPOSITION- Mary Ellen P. McNally, Karyn M. Usher, Steven W. Hansen, Jennifer S. Amoo, Allison P. Bernstein, "Precision of Internal Standard and External Standard Methods in High Performance Liquid Chromatography", Chromatography, vol. 33, no. Issue 4, (20150401), pages 1 - 14, XP055737407
OPPOSITION- VAN DE MERBEL, "The use of internal standards for macromolecule quantifacation by LC-MS: lessons learnt from small molecule essays", EBF Focus Workshop, Brussels , Belgium, (20110621), pages 1 - 44, XP055737416
OPPOSITION- WILSON et al., "Quantitative biochemical measurements", Principles and Techniques of Biochemistry and Molecular Biology, (20050000), pages 47 - 48, XP055737412
OPPOSITION- Alain Beck; Hélène Diemer; Daniel Ayoub; François Debaene; Elsa Wagner-Rousset; Christine Carapito; Alain Van Dorsselaer; Sarah Sanglier-Cianférani, "Analytical characterization of biosimilar antibodies and Fc-fusion proteins", TrAC Trends in Analytical Chemistry, (20130700), vol. 48, pages 81 - 95, XP055094402
OPPOSITION- Håkan Mellstedt, "Clinical considerations for biosimilar antibodies", EJC Supplements, (20130000), vol. 11, no. 3, pages 1 - 11, XP055218367
OPPOSITION- BECK et al., "Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry", Anal. Chem., (20120000), vol. 84, no. 11, pages 4637 - 4646, XP055054002
OPPOSITION- Giada Marino; Ulrich Eckhard; Christopher M Overall, "Protein Termini and Their Modifications Revealed by Positional Proteomics", ACS Chem. Biol., (20150000), vol. 10, pages 1754 - 1764, XP055506381
OPPOSITION- Oleg Klykova and Michael G. Weller, "Quantification of N-hydroxysuccinimide and N-hydroxysulfosuccinimide by hydrophilic interaction chromatography (HILIC)", Anal. Methods, (20150000), vol. 7, pages 6443 - 6448, XP055737397
OPPOSITION- LIU et al., "Human IgG2 Antibody Disulfide Rearrangement in Vivo", The Journal of Biological Chemistry, (20081024), vol. 283, no. 43, pages 29266 - 29272, XP002512406
OPPOSITION- LARSEN et al., BioTechniques, (20060600), vol. 40, pages 790 - 798, XP055737242
OPPOSITION- Mark Haverick, Selina Mengisen, Mohammed Shameem, Alexandre Ambrogelly, "Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications", mAbs, (20140700), vol. 6, no. 4, pages 852 - 858, XP055407190
OPPOSITION- VUGMEYSTER et al., "Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges", World J Biol Chem, (20120426), vol. 3, no. 4, pages 73 - 92, XP055307614
SEARCH- Fabian Benjamin Higel, "Dissertation zur Erlangung des Doktorgrades der Pharmacokinetic Profiling of Therapeutic Proteins and Variants by Mass Spectrometry", (20140911), URL: https://edoc.ub.uni-muenchen.de/17458/1/Higel_Fabian_Benjamin.pdf, (20160607), XP055287203 [Y] 2-15 * Chapter 6; Figure 4 *
SEARCH- REGNIER F E ET AL, "COMPARATIVE PROTEOMICS BASED ON STABLE ISOTOPE LABELING AND AFFINITY SELECTION", JOURNAL OF MASS SPECTROMETRY, WILEY, CHICHESTER, GB, (20020201), vol. 37, no. 2, doi:10.1002/JMS.290, ISSN 1076-5174, pages 133 - 145, XP009023411 [A] 1-15 * the whole document *
SEARCH- HIGEL FABIAN ET AL, "N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical", PHARMACEUTICAL RESEARCH, SPRINGER NEW YORK LLC, US, vol. 32, no. 11, doi:10.1007/S11095-015-1724-0, ISSN 0724-8741, (20150528), pages 3649 - 3659, (20150528), XP035553879 [Y] 2-15 * abstract *
SEARCH- HIGEL FABIAN ET AL, "N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, (20160113), vol. 100, doi:10.1016/J.EJPB.2016.01.005, ISSN 0939-6411, pages 94 - 100, XP029395648 [Y] 2-15 * abstract * * page 97 *
SEARCH- P. GILLERY ET AL, "Dosage de l'HbA1c et des produits d'Amadori en biologie humaine - [Assays of HbA(1c) and Amadori products in human biology]", ANNALES PHARMACEUTIQUES FRANÇAISES, FR, (20140506), vol. 72, no. 5, doi:10.1016/j.pharma.2014.04.002, ISSN 0003-4509, pages 330 - 336, XP055286564 [Y] 3-15 * abstract *
SEARCH- SHUANG YANG ET AL, "Glycomic Analysis by Glycoprotein Immobilization for Glycan Extraction and Liquid Chromatography on Microfluidic Chip", ANALYTICAL CHEMISTRY, (20131105), vol. 85, no. 21, doi:10.1021/ac4013013, ISSN 0003-2700, pages 10117 - 10125, XP055148101 [A] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents